Tybost
Product Images NDC 61958-1402

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tybost (NDC 61958-1402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tybost 01)

Chemical structure of the active ingredient in Tybost 150 mg, a compound featuring multiple ring systems including thiazole and piperazine rings, amide bonds, and aromatic phenyl groups.*

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

A pharmacokinetic figure showing GMR (90% CI) values for Darunavir and Cobicistat during second and third trimesters. It depicts total and unbound AUC and Cmin for Darunavir and total AUC and Cmin for Cobicistat, with data points and error bars representing 90% confidence intervals.*

FDA Label Image

Tybost 03

Label for Tybost (cobicistat) tablets 150 mg, containing 30 tablets per container. The label includes storage instructions at 25°C, a pharmacist alert about medicines that should not be taken with Tybost, and manufacturer information for Gilead Sciences, Inc. It notes the product is Rx only and made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.